Skip to main content

Analytik Jena Buys Imaging Firm UVP

NEW YORK (GenomeWeb News) – German analytical instrument firm Analytik Jena today announced it signed a contract to acquire life science imaging company UVP for an undisclosed price.

The deal is anticipated to close April 5, and, in addition to acquiring UVP, Analytik Jena will purchase the Upland, Calif.-based company's wholly owned subsidiary Ultra-Violet Products, headquartered in Cambridge, UK.

The deal launches Analytik Jena into the US market, it said.

UVP provides digital imaging systems for applications in proteomics, genomics, and plant and animal sciences. Among the instruments it offers are systems for gel and chemiluminescence imaging, as well as for fluorescent and colorimetric imaging.

The UVP group posted $17.2 million in revenues in 2012 and has 109 employees globally, Analytik Jena said. It anticipates the UVP business' operating results to reach breakeven in the second half of its Fiscal Year 2013. In FY 2014, sales from the business are expected to exceed €40 million ($51.3 million).

The deal follows last week's announcement from Analytik Jena that it launched its French subsidiary Analytik Jena France.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.